PDCD1 and cancer: Especially programmed cell death protein 1 (PD-1) and programmed cell death protein ligand 1 (PD-L1), ICIs expressed on the cell surface, can activate negative regulatory and dampen antitumor immune responses, leading to the escape of cancer cells from the host immune system [13,14].